Litfulo coupons
Litfulo

Litfulo Coupons & Discount Card - Compare Prices Near You

Litfulo (ritlecitinib) is prescribed to treat alopecia areata, an autoimmune disorder that leads to hair loss. This medication is suitable for adults and children 12 years and older. As a kinase inhibitor, Litfulo works by interfering with specific enzymes that play a role in the immune system's attack on hair follicles. It is taken orally in capsule form once daily. Common side effects may include headache and diarrhea. Always consult with a healthcare professional before starting any new medication to ensure it is appropriate for your condition.
Our Litfulo coupons are free to use. You can print the coupon, email it to yourself, or receive the Litfulo coupon via text message. To get your free discount, show the pharmacist your Litfulo savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Litfulo prices will update based on your prescription needs. Above our Litfulo coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Litfulo savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

50MG, Litfulo (30 Capsules)

Select pharmacy

Pharmacy logo

Rite Aid

$4425.59

COUPON PRICE
Pharmacy logo

Walgreens

$4613.58

COUPON PRICE

Litfulo savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$4425.59

BIN

ID

PCN

GRP

019876

LH2C847F54

CHIPPO

LHX

Powered by

This card is not insurance

Litfulo dosage forms

The average cost for 30 Capsules of Litfulo at 50MG is $4489.76 with a free coupon. This is 27.96% off the average retail price of $16059.99
DosageQuantityPrice fromPer unit
50MG30 Capsules$4489.76$149.66

Litfulo Warnings

When considering treatment with Ritlecitinib, it is important to be aware of the associated risks and necessary precautions. This medication can lower your immune system's ability to fight infections, leading to a heightened risk of serious infections. Additionally, there are potential risks related to cancer, cardiovascular issues, and allergic reactions. Below are key safety details:

  • Infection Risks: Ritlecitinib can compromise your immune system, increasing the likelihood of bacterial, viral, or fungal infections. This risk is higher if you are also taking other immune-suppressing drugs. Notify your doctor immediately if you experience symptoms like persistent cough, fever, chills, or a sore throat. Routine monitoring for infections is recommended, and testing for tuberculosis (TB) is necessary before and during treatment, especially if you have been in regions where TB and other fungal infections are prevalent.

  • Cancer Risks: There is a potential risk of developing cancers such as lymphoma and skin cancer while on Ritlecitinib. This risk may be elevated for smokers or those with a history of cancer. Regular skin examinations and monitoring for any unusual changes in your skin or unexplained weight loss are advised.

  • Cardiovascular and Blood Clot Risks: The medication may increase the risk of blood clots, heart attack, or stroke, particularly in individuals over 50 with existing heart disease risk factors, or those who smoke. Immediate medical attention is required if you experience symptoms such as chest pain, shortness of breath, sudden dizziness, or swelling in the legs.

  • Allergic Reactions: Although rare, serious allergic reactions, including anaphylaxis, may occur. Seek emergency medical care if you notice swelling of the lips, tongue, or throat, or have difficulty breathing.

  • Lab Test Changes: Ritlecitinib may cause changes in blood tests, such as reduced white blood cell or platelet counts and increased liver enzymes. Regular lab tests will be conducted to monitor these effects.

  • Vaccinations: Ensure all vaccinations are up-to-date before starting Ritlecitinib, and avoid live vaccines during treatment, as the effects of the medication on vaccine efficacy are unknown.

Discuss these risks and management strategies with your healthcare provider to ensure safe and informed use of Ritlecitinib.

Litfulo Side Effects

When taking this medication, it's important to be aware of potential side effects. Some common, typically mild side effects include headache, diarrhea, acne, rash, and hives. These symptoms usually don't cause significant issues, but if they persist or worsen, consulting a healthcare provider is advisable.

Other side effects might occur and may require attention if they become troublesome. These include fever, dizziness, small red bumps on the skin known as folliculitis, dry and itchy skin referred to as eczema, herpes zoster infections, and mouth ulcers or pain.

Rare but serious side effects demand immediate medical attention. These include signs of a stroke such as sudden weakness, speech difficulties, and confusion; arterial thrombosis characterized by chest pain and shortness of breath; pulmonary embolism with symptoms like cough and chest pain; and deep vein thrombosis, indicated by leg cramps and swelling. Additionally, serious bleeding issues, as well as severe infections, should be promptly addressed. An allergic reaction, which is also rare, can manifest as hives, rash, faintness, trouble breathing, and swelling of the lips or tongue. If any severe symptoms arise, seeking urgent medical care is crucial.

Litfulo Interactions

A product that may interact with this drug is: rifampin.
Litfulo FAQs
Does litfulo work for hair loss?

Litfulo (ritlecitinib) is a medication that has been studied for its potential use in treating alopecia areata, an autoimmune condition that causes hair loss. Clinical trials have shown that it can be effective in promoting hair regrowth in individuals with this condition. However, its effectiveness for other types of hair loss, such as androgenetic alopecia, is not established. It is important for individuals to consult with a healthcare provider to determine the most appropriate treatment for their specific type of hair loss.

Litfulo is a medication developed by Pfizer, known generically as ritlecitinib. It is used for the treatment of alopecia areata, an autoimmune condition that causes hair loss. Ritlecitinib is a Janus kinase (JAK) inhibitor, which works by modulating the immune system to reduce inflammation and prevent hair loss.

Litfulo (ritlecitinib) has shown promising results in clinical trials for the treatment of alopecia areata, an autoimmune condition that causes hair loss. In studies, a significant number of patients experienced substantial hair regrowth after using Litfulo. However, individual responses can vary, and it is important for patients to discuss with their healthcare provider to determine if it is an appropriate treatment option for their specific condition.

Litfulo (ritlecitinib) is primarily indicated for the treatment of alopecia areata, an autoimmune condition that causes patchy hair loss. It is not specifically approved for general thinning hair or other types of hair loss. It is important for individuals to consult with a healthcare provider to determine the appropriate treatment for their specific condition.

The high cost of Litfulo can be attributed to several factors. These include the extensive research and development required to bring the medication to market, the costs associated with clinical trials, and the regulatory approval process. Additionally, the pricing may reflect the drug's effectiveness, the complexity of its manufacturing process, and the investment needed to ensure its safety and efficacy. Market exclusivity and patent protection can also play a role in the pricing strategy.